Stockscreener 앱 받기
8.08
1.00%
0.08
시간 외 거래:
8.06
-0.02
-0.25%
Emergent Biosolutions Inc 주식(EBS)의 최신 뉴스
Emergent BioSolutions signs contract modification award for CNJ-016 - MSN
Emergent BioSolutions authorizes $50 million stock repurchase program - MSN
U.S. Smallpox Treatment Market: See Incredible Growth - openPR.com
3 Vaccine Stocks Worth a Second Look as Mpox Is on the Rise in the U.S. - Barron's
Emergent BioSolutions outlines $720M–$760M 2026 revenue target as transformation plan advances - MSN
EBS Forecast, Price Target & Analyst Ratings | EMERGENT BIOSOLUTIONS INC (NYSE:EBS) - ChartMill
How The Investment Narrative For Emergent BioSolutions (EBS) Is Shifting After The $12 Target Reset - Yahoo Finance
BioThrax (Emergent BioSolutions) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F - Yahoo Finance
H.C. Wainwright cuts Emergent BioSolutions stock price target on revenue miss - Investing.com Nigeria
HC Wainwright Lowers Emergent Biosolutions (NYSE:EBS) Price Target to $12.00 - MarketBeat
EBS: HC Wainwright Lowers Price Target to $12, Maintains Buy Rat - GuruFocus
Macro Review: Is Emergent BioSolutions Inc currently under institutional pressure2026 Key Highlights & AI Powered Market Trend Analysis - baoquankhu1.vn
Market Catalysts: Is Emergent BioSolutions Inc. stock showing strong momentum2026 Snapshot & Comprehensive Market Scan Reports - baoquankhu1.vn
Emergent Biosolutions (NYSE:EBS) Cut to Hold at Wall Street Zen - MarketBeat
Why Emergent BioSolutions Inc. stock is favored by hedge funds2026 Geopolitical Influence & Entry Point Confirmation Signals - Naître et grandir
Sentiment Recap: Can Emergent BioSolutions Inc stock outperform in a bear marketEntry Point & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Emergent BioSolutions (NYSE: EBS) CFO reports unexercised option expirations - Stock Titan
Emergent BioSolutions (EBS) director granted 5,006 restricted stock units - Stock Titan
Emergent BioSolutions (NYSE: EBS) SVP awarded 44,834 stock options - Stock Titan
Emergent BioSolutions (EBS) CFO awarded 72,856 options, withholds 23,650 shares for taxes - Stock Titan
Emergent BioSolutions (EBS) EVP gets 44,834 options and 8,199 tax-withheld shares - Stock Titan
EBS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Emergent BioSolutions (EBS) SVP reports 116-share tax-withholding disposition - Stock Titan
Emergent BioSolutions (EBS) CFO logs 683-share tax-withholding disposition - Stock Titan
Emergent BioSolutions (EBS) EVP has 313 shares withheld for RSU taxes - Stock Titan
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors - The Globe and Mail
Emergent BioSolutions announces appointment of John D. Fowler, Jr. to board of directors - marketscreener.com
Emergent BioSolutions Adds Independent Director Amid Turnaround Efforts - TipRanks
Emergent BioSolutions appoints John D. Fowler, Jr. as director and Audit and Finance Committee member - TradingView
John Fowler joins Emergent BioSolutions (NYSE: EBS) board, Audit role - Stock Titan
Emergent Biosolutions Announces Appointment Of John D. Fowler, Jr. To Board Of Directors - TradingView
Former Wells Fargo banker John Fowler joins Emergent BioSolutions board - Stock Titan
Emergent Biosolutions secures new contracts with Public Health Agency of Canada and Defence Department - Traders Union
Aug Levels: Is Emergent BioSolutions Inc stock showing strong momentumPortfolio Performance Summary & Accurate Intraday Trading Signals - baoquankhu1.vn
Q4 2025 Emergent BioSolutions Inc Earnings Call Transcript - GuruFocus
Dow Dips Over 600 Points; US Producer Prices Increase In January - Sahm
Emergent BioSolutions Earnings: Revenue, Margins And GAAP Losses Paint Mixed Picture (EBS) - Seeking Alpha
Wall Street Zen Downgrades Emergent Biosolutions (NYSE:EBS) to Buy - MarketBeat
Emergent Biosolutions Q4 Earnings Call Highlights - MarketBeat
Emergent BioSolutions (EBS) One Off Loss Clouds Return To Profitability Narrative - simplywall.st
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Emergent BioSolutions (EBS) Stock Falls on Disappointing Revenue Guidance - GuruFocus
Emergent BioSolutions authorizes $50M stock buyback program By Investing.com - Investing.com India
Why Did Emergent Biosolutions Stock Tumble 20% After-Hours Today? - Stocktwits
Emergent BioSolutions Inc. (EBS): Investor Outlook Reveals 21.62% Potential Upside Amidst Challenging Revenue Growth - DirectorsTalk Interviews
Emergent BioSolutions Stock Pre-Market (-21%): Q4 Revenue Miss & Weak NARCAN Sales - Trefis
Emergent BioSolutions Inc (EBS) Q4 2025 Earnings Call Highlights: Strategic Gains Amid Revenue Challenges - GuruFocus
Emergent BioSolutions Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:EBS) 2026-02-26 - Seeking Alpha
Earnings call transcript: Emergent Biosolutions Misses Q4 2025 Expectations, Stock Edges Up - Investing.com Australia
Emergent Biosolutions: Q4 Earnings Snapshot - theheraldreview.com
Earnings call transcript: Emergent Biosolutions Misses Q4 2025 Expectations, Stock Edges Up By Investing.com - Investing.com South Africa
Emergent BioSolutions (EBS) Projects Significant Growth in FY26 Earnings - GuruFocus
Emergent BioSolutions (EBS) Eyes Global Expansion and Growth Ini - GuruFocus
Emergent BioSolutions Q4 2025 slides: transformation advances despite revenue miss - Investing.com
Emergent BioSolutions secures $140M contracts with Canada - Investing.com Canada
2.02%
0.77%
자본화:
|
볼륨(24시간):